The Scientist

» diagnostics

Most Recent

A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.

1 Comment

image: Art’s Diagnosticians

Art’s Diagnosticians

By | June 12, 2017

Physicians peer into the subjects of artistic masterpieces, and find new perspective on their own approach to diagnosing maladies.

0 Comments

image: Companies Pursue Diagnostics that Mine the Microbiome

Companies Pursue Diagnostics that Mine the Microbiome

By | May 23, 2017

Tests so far typically screen for risky patterns that may augment traditional types of clinical data.

0 Comments

image: A Triple Threat

A Triple Threat

By | May 22, 2017

The mosquitoes that carry Zika may be able to transmit two other viruses at the same time.

0 Comments

image: Refunds Coming to Theranos’s Arizona Customers

Refunds Coming to Theranos’s Arizona Customers

By | April 20, 2017

The blood-testing startup settles a legal dispute with the Arizona attorney general’s office.

0 Comments

image: CRISPR-Based Nucleic Acid Test Debuts

CRISPR-Based Nucleic Acid Test Debuts

By | April 13, 2017

SHERLOCK combines CRISPR-Cas13a with isothermal RNA amplification to detect RNA and DNA with single-base specificity.

0 Comments

image: Rapid Blood-Type Test

Rapid Blood-Type Test

By | March 16, 2017

Researchers describe a paper-based blood test that can determine a person’s blood type in just two minutes.

0 Comments

image: Infant Brain Scans May Predict Autism Diagnosis

Infant Brain Scans May Predict Autism Diagnosis

By | February 17, 2017

A computer algorithm can identify the brains of autism patients with moderate accuracy based on scans taken at six months and one year of age.

0 Comments

image: Pharma Cooperates to Achieve Precision Medicine

Pharma Cooperates to Achieve Precision Medicine

By | February 1, 2017

The challenges of adapting drug development to the age of personalized therapies encourage collaboration among industry players.

0 Comments

Ambry Genetics CEO Aaron Elliott discusses his team’s recent analysis of 20,000 clinical next-generation sequencing panels.

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Judge Recommends Ruling to Block Internet Access to Sci-Hub
  3. Opinion: Microbiology Needs More Math
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech